MAX
日程 AdvisorShares Psychedelics ETF
简单的时间表
延长时间表
主要参数
| 10夏季盈利能力 | 0 |
| 3夏季盈利能力 | 32.79 |
| 5夏季盈利能力 | 0 |
| ISIN代码 | US00768Y3624 |
| beta | 0.4 |
| 公司数量 | 13 |
| 前10名发行人，％ | 57.12 |
| 国家 | USA |
| 国家ISO | US |
| 地区 | Global |
| 基地的日期 | 2021-09-15 |
| 委员会 | 0.99 |
| 平均p/bv | 1.75 |
| 平均p/e | 9.46 |
| 平均p/s | 2.15 |
| 年度盈利能力 | 20.42 |
| 所有者 | AdvisorShares |
| 指数 | ACTIVE - No Index |
| 神的盈利能力 | 0.31 |
| 网站 | 系统 |
| 货币 | usd |
| 资产类型 | Equity |
| 当天变化 | 0% 17.028 $ |
| 一周的变化 | -1.6% 17.305 $ |
| 一个月的变化 | -0.83% 17.17 $ |
| 在三个月内变化 | -8.5% 18.61 $ |
| 六个月内改变 | -16.42% 20.373 $ |
| 一年的变化 | +20.42% 14.14 $ |
| 从年初开始变化 | -0.61% 17.133 $ |
支付订阅
可以通过订阅获得更多的功能和数据，用于分析公司和投资组合
顶级公司
| 姓名 | 行业 | 分享, % | P/BV | P/S | P/E | EV/Ebitda | 股息产量 | |
| #1 |
 COMPASS Pathways plc |
Healthcare | 7.8644 | 1.65 | 0 | -1.91 | -0.69 | 0 |
| #2 |
 Alkermes plc |
Healthcare | 7.7698 | 3.32 | 3.13 | 13.27 | 9.4 | 0 |
| #3 |
 Relmada Therapeutics, Inc. |
Healthcare | 6.6722 | 0.39 | 0 | -0.21 | -0.12 | 0 |
| #4 |
 GH Research PLC |
Healthcare | 6.1726 | 2.04 | 0 | -17.08 | -6.96 | 0 |
| #5 |
 Neurocrine Biosciences |
Healthcare | 5.8272 | 5.49 | 6.03 | 41.64 | 22.57 | 0 |
| #6 |
 Supernus Pharmaceuticals, Inc. |
Healthcare | 5.2346 | 1.99 | 3.12 | 27.96 | 11.39 | 0 |
| #7 |
 Alto Neuroscience, Inc. |
Healthcare | 5.0798 | 1.93 | 0 | -1.26 | -2.06 | 0 |
| #8 |
 AbbVie |
Healthcare | 4.6133 | 92.87 | 6.64 | 96.15 | 25.13 | 2.97 |
| #9 |
 Johnson & Johnson |
Healthcare | 4.3527 | 4.83 | 3.88 | 24.53 | 14.43 | 2.79 |
| #10 |
 NRx Pharmaceuticals, Inc. |
Healthcare | 3.5295 | -0.69 | 0 | -1.21 | -1.15 | 0 |
相似的 ETF
管理公司的其他ETF
| 姓名 | 班级 | 类别 | 委员会 | 年度盈利能力 |
| Equity | 0.83 | 61.39 | ||
| Equity | 0.84 | -0.91 | ||
| Equity | 1.18 | 8.94 | ||
| Equity | 0.95 | -5.36 | ||
| Equity | 1.28 | 23.28 | ||
| Multi-Asset | 1.71 | 11.95 | ||
| Equity | 1.03 | 50.52 | ||
| Equity | 0.9 | 14.31 | ||
| Equity | 1.1 | 21.77 | ||
| Multi-Asset | 1.51 | 21.53 | ||
| Equity | 0.75 | 11.26 | ||
| Equity | 2.84 | -17.15 | ||
| Equity | 1 | 7.68 | ||
| Equity | 1.01 | -9.01 | ||
| Equity | 0.99 | 1.65 |
描述 AdvisorShares Psychedelics ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.
基于来源: porti.ru
